Abstract |
Immunotherapy is one of the key strategies for cancer treatment. The cGAS-cGAMP-STING-IRF3 pathway of cytosolic DNA sensing plays a pivotal role in antiviral defense. We report that the STING activator cGAMP possesses significant antitumor activity in mice by triggering the STING-dependent pathway directly. cGAMP enhances innate immune responses by inducing production of cytokines such as interferon-β, interferon-γ, and stimulating dendritic cells activation, which induces the cross-priming of CD8(+) T cells. The antitumor mechanism of cGAMP was verified by STING and IRF3, which were up-regulated upon cGAMP treatment. STING-deficiency dramatically reduced the antitumor effect of cGAMP. Furthermore, cGAMP improved the antitumor activity of 5-FU, and clearly reduced the toxicity of 5-FU. These results demonstrated that cGAMP is a novel antitumor agent and has potential applications in cancer immunotherapy.
|
Authors | Tiejun Li, Hao Cheng, Hong Yuan, Qiming Xu, Chang Shu, Yuefan Zhang, Pengbiao Xu, Jason Tan, Yaocheng Rui, Pingwei Li, Xiangshi Tan |
Journal | Scientific reports
(Sci Rep)
Vol. 6
Pg. 19049
(Jan 12 2016)
ISSN: 2045-2322 [Electronic] England |
PMID | 26754564
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Cytokines
- Interferon Regulatory Factor-3
- Irf3 protein, mouse
- Membrane Proteins
- Nucleotides, Cyclic
- Sting1 protein, mouse
- cyclic guanosine monophosphate-adenosine monophosphate
- Nucleotidyltransferases
- cGAS protein, mouse
- Fluorouracil
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cytokines
(metabolism)
- Dendritic Cells
(drug effects, metabolism)
- Fluorouracil
(pharmacology, toxicity)
- Immunity, Innate
(drug effects)
- Interferon Regulatory Factor-3
(metabolism)
- Membrane Proteins
(metabolism)
- Mice, Inbred BALB C
- Nucleotides, Cyclic
(pharmacology)
- Nucleotidyltransferases
(metabolism)
|